Frequently Asked Questions
The Prostate Cancer Therapeutics Market will be worth USD 21.90 billion in the forecast period by 2029.
The Prostate Cancer Therapeutics Market growth rate is 8.2% during the forecast period.
The rise in the number of cases of prostate cancer and cardiovascular disorders are the growth drivers of the Prostate Cancer Therapeutics Market.
The drug class, end-users and distribution channel are the factors on which the Prostate Cancer Therapeutics Market research is based.
Major companies in the Prostate Cancer Therapeutics Market are Johnson & Johnson Private Limited, Astellas Pharma Inc., Ipsen Pharma, Sanofi, Bayer AG, AbbVie Inc., AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott, Takeda Pharmaceutical Company Limited., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Myovant Sciences GmbH, Tolmar Pharmaceuticals, Inc., Ferring B.V., Dendreon Pharmaceuticals LLC., and Genentech, Inc.
